AI assistant
Sending…
Inogen Inc — Director's Dealing 2021
Apr 1, 2021
33625_dirs_2021-03-31_af84d8c4-f385-4361-8ce9-894cc409b09b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2021-03-23
Reporting Person: Huggenberger Raymond (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-23 | Common Stock | M | 6087 | $16.62 | Acquired | 20916 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-23 | Stock Option (Right to Buy) | $16.62 | M | 6087 | Disposed | 2021-03-31 | Common Stock (6087) | Direct |
Footnotes
F1: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014.
More from Inogen Inc
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 27